|Número de publicación||US20050075680 A1|
|Tipo de publicación||Solicitud|
|Número de solicitud||US 10/891,834|
|Fecha de publicación||7 Abr 2005|
|Fecha de presentación||15 Jul 2004|
|Fecha de prioridad||18 Abr 2003|
|También publicado como||EP1786508A2, EP1786508A4, US8718777, US20090292344, WO2006019766A2, WO2006019766A3|
|Número de publicación||10891834, 891834, US 2005/0075680 A1, US 2005/075680 A1, US 20050075680 A1, US 20050075680A1, US 2005075680 A1, US 2005075680A1, US-A1-20050075680, US-A1-2005075680, US2005/0075680A1, US2005/075680A1, US20050075680 A1, US20050075680A1, US2005075680 A1, US2005075680A1|
|Inventores||David Lowry, Brad Fowler, Gene Thompson|
|Cesionario original||Lowry David Warren, Brad Fowler, Gene Thompson|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (99), Citada por (43), Clasificaciones (14), Eventos legales (2)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
This application is a continuation-in-part of pending U.S. application Ser. No. 10/418,796, filed Apr. 18, 2003, and incorporated herein in its entirety by reference.
The present invention relates to intracranial electrodes and methods for implanting and using intracranial electrodes. These electrodes and methods may be suited for neurostimulation systems and may also be used in electroencephalography and other recording systems, e.g., evoked potential recordings.
A wide variety of mental and physical processes are known to be controlled or influenced by neural activity in the central and peripheral nervous systems. For example, the neural functions in some areas of the brain (e.g., the sensory or motor cortices) are organized according to physical or cognitive functions. Several other areas of the brain also appear to have distinct functions in most individuals. In the majority of people, for example, the areas of the occipital lobes relate to vision, the regions of the left inferior frontal lobes relate to language, and the regions of the cerebral cortex appear to be involved with conscious awareness, memory, and intellect. Because of the location-specific functional organization of the brain, in which neurons at discrete locations are statistically likely to control particular mental or physical functions in normal individuals, stimulating neurons at selected locations of the central nervous system can be used to effectuate changes in cognitive and/or motor functions throughout the body.
In several existing applications, neural functions are treated by electrical or magnetic stimulation powered by a neural stimulator that has a plurality of therapy electrodes and a pulse system coupled to the therapy electrodes. The therapy electrodes can be implanted into the patient at a target site for stimulating the desired portions of the brain. For example, one existing technique for masking pain in a patient is to apply an electrical stimulus to a target stimulation site of the brain.
The brain can be stimulated in several known fashions. One type of treatment is referred to as transcranial electrical stimulation (TES), which involves placing an electrode on the exterior of the patient's scalp and delivering an electrical current to the brain through the scalp and the skull. TES, however, is not widely used because the delivery of the electrical stimulation through the scalp and the skull causes patients a great amount of pain and the electrical field is difficult to direct or focus accurately.
Another type of treatment is transcranial magnetic stimulation (TMS), which involves using a high-powered magnetic field adjacent the exterior of the scalp over an area of the cortex. TMS does not cause the painful side effects of TES. Unfortunately, TMS is not presently effective for treating many patients because the existing delivery systems are not practical for applying stimulation over an adequate period of time. TMS systems, for example, are relatively complex and require stimulation treatments to be performed by a healthcare professional in a hospital or physician's office. The efficacy of TMS in longer-term therapies may be limited because it is difficult to (a) accurately localize the region of stimulation in a reproducible manner, (b) hold the device in the correct position over the cranium for the requisite period, and (c) provide stimulation for extended periods of time.
Another device for stimulating a region of the brain is disclosed by King in U.S. Pat. No. 5,713,922, the entirety of which is incorporated herein by reference. King discloses a device for cortical surface stimulation having electrodes mounted on a paddle that is implanted under the skull of the patient. These electrodes are placed in contact with the surface of the cortex to create “paresthesia,” which is a vibrating or buzzing sensation. Implanting the paddle typically requires removal of a relatively large (e.g., thumbnail-sized or larger) window in the skull via a full craniotomy. Craniotomies are performed under a general anesthetic and subject the patient to increased chances of infection.
A physician may employ electroencephalography (EEG) to monitor neural functions of a patient. Sometimes this is done alone, e.g., in diagnosing epileptic conditions, though it may also be used in conjunction with neurostimulation. Most commonly, electroencephalography involves monitoring electrical activity of the brain, manifested as potential differences at the scalp surfaces, using electrodes placed on the scalp. The electrodes are typically coupled to an electroencephalograph to generate an electroencephalogram. Diagnosis of some neurological diseases and disorders, e.g., epilepsy, may best be conducted by monitoring neural function over an extended period of time. For this reason, ambulatory electroencephalography (AEEG) monitoring is becoming more popular. In AEEG applications, disc electrodes are applied to the patient's scalp. The scalp with the attached electrodes may be wrapped in gauze and the lead wires attached to the electrodes may be taped to the patient's scalp to minimize the chance of displacement.
EEG conducted with scalp-positioned electrodes requires amplification of the signals detected by the electrodes. In some circumstances, it can be difficult to pinpoint the origin of a particular signal because of the signal dissipation attributable to the scalp and the skull. For more precise determinations, EEG may be conducted using “deep brain” electrodes. Such electrodes extend through the patient's scalp and skull to a target location within the patient's brain. Typically, these deep brain electrodes comprise lengths of relatively thin wire that are advanced through a bore through the patient's skull to the desired location. If the electrodes are to be monitored over an extended period of time, the electrodes typically are allowed to extend out of the patient's skull and scalp and are coupled to the electroencephalograph using leads clipped or otherwise attached to the electrodes outside the scalp. To avoid shifting of the electrodes over time, the electrodes typically are taped down or held in place with a biocompatible cementitious material. The patient's head typically must be wrapped in gauze to protect the exposed electrodes and the associated leads, and the patient is uncomfortable during the procedure. This may be suitable for limited testing purposes-deep brain encephalography typically is limited to tests conducted in hospital settings over a limited period of time, usually no more than a few days-but could be problematic for longer-term monitoring, particularly in nonclinical settings.
Screws have been used to attach plates or the like to patients' skulls.
Various embodiments of the present invention provide intracranial electrodes and methods for implanting and using intracranial electrodes. It will be appreciated that several of the details set forth below are provided to describe the following embodiments in a manner sufficient to enable a person skilled in the art to make and use the disclosed embodiments. Several of the details and advantages described below, however, may not be necessary to practice certain embodiments of the invention. Additionally, the invention can also include additional embodiments that are not described in detail with respect to
One aspect of the invention is directed to an intracranial signal transmission system that includes a generally electrically insulating support body having a head portion configured to be positioned at least proximate to an outer surface of a patient's skull. The support body can further have a shaft portion configured to extend into an aperture in the patient's skull. At least one electrical contact portion is carried by the support body and can be positioned to transfer electrical signals to, from, or both to and from the patient's brain via the aperture in the patient's skull.
An intracranial signal transmission system in accordance with another aspect of the invention includes an electrical contact portion configured to be positioned in an aperture of a patient's skull, and an electrical energy transfer device configured to be releasably positioned external to the patient's scalp. The energy transfer device can be coupleable to a signal transmitter to transmit signals to the electrical contact portion while the electrical contact portion is positioned beneath the patient's scalp, and while the energy transfer device is positioned external to the patient's scalp. In particular embodiments, the electrical energy transfer device can include a flexible outer layer, an adhesive gel layer positioned to contact the patient's scalp, a conductive layer positioned between the outer layer and the adhesive gel layer, and a conductive lead connected to the conductive layer.
An intracranial signal transmission system in accordance with still another aspect of the invention includes a shaft configured to extend through an aperture in a patient's skull, and a head connected to the shaft. The head can be configured to be positioned adjacent to an external surface of the patient's skull and can be eccentrically positioned relative to the shaft. Accordingly, the head can have a first portion extending outwardly from the shaft by a first distance, and a second portion extending outwardly from the shaft by a second distance different from the first distance. The system can further include an electrical contact portion carried by at least one of the shaft and the head.
Other aspects of the invention are directed to methods for installing electrodes and/or transmitting intracranial electrical signals. A method in accordance with one aspect of the invention includes drilling a hole in a patient's skull, and determining a distance from an outer surface of the patient's skull to a feature beneath the outer surface of the patient's skull by inserting an elongated member having graduation markings into the pilot hole. The method can further include selecting a size of an intracranial electrode based on the distance determined with the elongated member, and inserting the intracranial electrode into the hole. The method can still further include securing the intracranial electrode to the patient's skull.
A method in accordance with another aspect of the invention includes forming an aperture in a patient's skull, with the aperture having a first generally conical portion with a first diameter at an external surface of the patient's skull, and a second portion having a second diameter smaller than the first diameter, located beneath the external surface. The method can further include disposing proximate to the aperture an electrical contact portion carried by a support body having a shaft and a head depending from the shaft. The head can have a generally conical shape, with an angle between an external surface of the shaft and an external surface of the head being obtuse. The method can still further include inserting the support body into the aperture so that the shaft extends through the second portion of the aperture and the head engages a wall of the aperture at the first portion of the aperture.
A method in accordance with yet another aspect of the invention includes forming an aperture in the patient's skull, disposing proximate to the aperture an electrical contact portion carried by a support body having a shaft and a head depending from the shaft, with the shaft having an external surface and a plurality of surface features. The method can still further include inserting the support body into the aperture so that the shaft extends into the aperture, and then allowing the patient's bone tissue to grow into interengagement with the surface features.
For ease of understanding, the following discussion is subdivided into three areas of emphasis. The first section discusses certain intracranial electrodes; the second section relates to select embodiments of neurostimulation systems; and the third section outlines methods in accordance with other embodiments of the invention.
B. Intracranial Electrodes
FIGS. 2A-B illustrate an intracranial electrode 100 in accordance with one embodiment of the invention. This electrode 100 includes a head 102 attached to a threaded shaft 110. The head 102 and shaft 110 may be integrally formed of an electrically conductive material, e.g., titanium or another biocompatible, electrical conductive metal. The head 102 may include one or more slots 104, an allen head recess (not shown), or other structure (e.g., a square drive or TORX™ drive recess) adapted to facilitate turning the electrode 100. As the electrode 100 is turned, the threads 112 of the threaded shaft 110 will advance a generally distally positioned contact surface 115 of the electrode 100 toward the dura mater 20. The length of the shaft 110 may be selected so that the contact surface 115 of the electrode 100 electrically engages the surface of the dura mater 20 without causing undue harm to the dura mater 20 or the underlying cerebral cortex. The contact surface 115 may comprise a relatively blunt end to reduce trauma to the dura mater and the underlying brain tissue 25.
In one embodiment, the intracranial electrode 100 is adapted to be electrically connected to a pulse system (1050 in
The head 102 of the electrode 100 is adapted to be implanted subcutaneously beneath the patient's scalp 30 (shown schematically in
The dimensions of the electrode 100 can be varied to meet various design objectives. In one embodiment, however, the electrode 100 is longer than the thickness of the patient's skull. More specifically, the head 102 is adapted to be seated at an extracranial subcutaneous site while the threaded shaft 110 is only slightly longer than the skull thickness at the intended treatment site. Lengths on the order of 4-50 mm, for example, may be appropriate in certain applications. The diameter of the head 102 and the threaded shaft 110 may also be varied. For most applications, shafts 110 having diameters (typically excluding the width of the threads 112) of no greater than 4 mm will suffice. Shaft diameters of about 1-4 mm are likely, with diameters of 1.5-2.5 mm being well suited for most applications. FIGS. 2A-B illustrate an electrode 100 having a constant diameter shaft 110, but it should be understood that the shaft diameter may vary. For example, the shaft 110 may taper distally to improve the ability of the shaft 110 to be self-tapping. The head 102 typically will have a larger diameter than an adjoining portion of the shaft 110. (It should be recognized that
The connection of the electrode 150 to the lead 160 in FIGS. 3A-B differs somewhat from the connection of the electrode 100 and lead 120 in FIGS. 2A-B, however. In FIGS. 2A-B, the electrode 100 is electrically coupled to the lead 120 by compressively engaging the electrically conductive ring 122 of the lead 120 between the electrode head 102 and the skull 10. In FIGS. 3A-B, the electrode 150 includes a head 152 including slots 154 or other structure for engaging a screwdriver, wrench, or the like. The head 152 is adapted to engage a cap 162 carried by the lead 160 that electrically couples the body 164 of the lead 160 to the head 152 of the electrode 150. In the illustrated embodiment, the cap 162 comprises a dielectric body (e.g., a dielectric plastic material with some resilience) having an electrically conductive inner surface 163, which may be provided by coating an interior surface of the cap 162 with a metal. In one embodiment, the cap 162 is adapted to resiliently deform to be press-fitted on the head 152. The body 164 of the lead 160 may be coupled to the electrically conductive inner surface 163 of the cap 162, thereby providing an electrical pathway between the electrode 150 and a pulse system (not shown) operatively coupled to the lead 160.
In one embodiment, the cap 162 is sized to be subcutaneously implanted beneath the patient's scalp 30. In the illustrated embodiment, the head 152 and the cap 162 both extend outwardly beyond the outer cortex 12 of the patient's skull 10. In another embodiment (discussed in more detail below with respect to
FIGS. 4A-B schematically illustrate aspects of an intracranial electrode 200 in accordance with another embodiment. The electrode 200 may comprise an electrically conductive inner portion 205 and an electrically insulative outer portion 206. In the illustrated embodiment, the electrically conductive portion 205 of the electrode 200 includes a head 202 and a threaded shaft 210 defining a contact surface 215 for electrically contacting the patient's dura mater 20. These elements of the electrode 200 and their electrical connection to the lead 120 are directly analogous to the electrode 100 shown in FIGS. 2A-B. The electrically insulative outer portion 206 of the electrode 200 shown in
When implanted in a skull 10 as shown in
In one particular embodiment, the dielectric layer 280 comprises an electrically insulative ceramic material. In another embodiment, the dielectric layer 280 comprises an electrically insulative plastic or other biocompatible polymer that has sufficient structural integrity to adequately anchor the electrode 250 to the skull 10 for the duration of its intended use. If so desired, the dielectric layer 280 may be porous or textured to promote osseointegration of long-term implants. For shorter-term applications, the dielectric layer 280 may be formed of or covered with a material that will limit osseointegration.
In at least some of the preceding embodiments, the intracranial electrode 100, 150, 200, or 250 has a fixed length. In the embodiment shown in FIGS. 2A-B, for example, the distance between the base of the head 102 and the contact surface 115 remains fixed. When the threaded shaft 110 is sunk into the skull 10 to a depth sufficient to compress the conductive ring 122 of the lead 120 between the head 102 and the skull 10, this will also fix the distance from the exterior surface of the outer cortex 12 of the skull 10 to the contact surface 115. The thickness of the skull 10 can vary from patient to patient and from site to site on a given patient's skull. Hence, the pressure exerted by the contact surface 115 against the dura mater 20 will vary depending on the thickness of the skull. If the electrode 100 is selected to be long enough to make adequate electrical contact with the dura mater adjacent the thickest site on a skull, the pressure exerted by the contact surface 115 against the dura mater 20 may cause undue damage at sites where the skull is thinner. Consequently, it can be advantageous to provide a selection of electrode sizes from which the physician can choose in selecting an electrode 100 for a particular site of a specific patient's skull.
The intracranial electrode 300 of
The head 320 of the electrode 300 comprises a body 322 and a tubular length 324 that extends from the body 322. The body 322 may be adapted to be rotated by hand or by an installation tool. In one embodiment the body 322 is generally hexagonal to facilitate rotation with an appropriately sized wrench. In the particular embodiment shown in FIGS. 6A-B, the body 322 has a pair of recesses 323 in its outer face sized and shaped to interface with a dedicated installation tool (not shown) having projections adapted to fit in the recesses 323. If so desired, the installation tool may be a torque wrench or other tool adapted to limit the amount of torque an operator may apply to the head 320 of the electrode 300 during installation. The tubular length 324 may be externally threaded so the head 320 may be anchored to the skull 10 by screwing the tubular length 324 into the skull 10.
The head 320 includes an internally threaded bore 326 that extends through the thickness of the body 322 and the tubular length 324. The bore 326 has threads sized to mate with the external threads on the shaft 310. If so desired, a biocompatible sealant (e.g., a length of polytetrafluoroethylene tape) may be provided between the threads of the bore 326 and the threads of the shaft 310 to limit passage of fluids or infectious agents through the bore 326.
Rotation of the shaft 310 with respect to the head 320 will, therefore, selectively advance or retract the shaft 310 with respect to the head 320. This will, in turn, increase or decrease, respectively, the distance between the lower face 323 of the head body 322 and the contact surface 315 of the shaft 310. As suggested in
If so desired, the torque driver 340 may include graduations 342 to inform the physician how far the shaft 310 has been advanced with respect to the head 320. As noted below, in certain methods of the invention, the thickness of the skull at the particular treatment site may be gauged before the electrode 300 is implanted. Using this information and the graduations 342 on the torque driver 340, the physician can fairly reliably select an appropriate length for the electrode 300 to meet the conditions present at that particular site.
In the embodiment shown in FIGS. 6A-B, the head 320 and the shaft 310 are both formed of an electrically conductive material. The conductive ring 122 of the lead 120 may be received in a slot formed in the lower face 323 of the body 322. Alternatively, the ring 122 may be internally threaded, permitting it to be threaded over the external threads of the tubular length 324 before the head 320 is implanted. If so desired, the ring 122 can instead be compressively engaged by the lower face 323 of the head 320 in a manner analogous to the engagement of the head 102 with the ring 122 in
In another embodiment, the head 320 is formed of a dielectric material, such as a dielectric ceramic or plastic. This may necessitate a different connection between the lead 120 and the shaft 310, such as by electrically contacting the lead 120 to the proximal end 312 of the shaft 310. Employing a dielectric head 320 can help electrically insulate the skull 10 from the electrodes 300, improving signal quality and reducing interference between the various electrodes 300 in an array, as noted above.
The intracranial electrode 350 of this embodiment also includes a head 370 having an internally threaded bore 376 extending through its thickness. The threads of the bore 376 are adapted to mate with the threads of the first threaded portion 360 a. By rotating the shaft 360 with respect to the head 370 (e.g., with a screwdriver 340), the distance between the head 370 and the contact surface 365 can be adjusted in much the same manner described above in connection with FIGS. 6A-B.
The head 320 of the electrode 300 in FIGS. 6A-B has an externally threaded tubular length 324 that extends into the skull 10 and helps anchor the electrode 300 to the skull 10. The shaft 310 may then move with respect to the skull by rotating the shaft 310 with respect to the head 320. In the embodiment shown in
In the embodiment of
In the preceding embodiments, some or a majority of the head of the electrode extends outwardly beyond the outer surface of the skull 10. In the particular implementation shown in
The head 420 includes a base 430 and an actuator 422. The base 430 includes an externally threaded body 432 and a tubular length 434 that extends from the body 432. A portion of the tubular length 434 carries external threads 436. The tubular length 434 may also include one or more locking tabs 440, each of which includes an actuating surface 442.
The actuator 422 has an internally threaded bore 424 that is adapted to matingly engage the threads 436 on the base 430. Rotating the actuator 422 with respect to the base 430 in a first direction will advance the actuator 422 toward the actuating surface 442 of each of the tabs 440. The actuator 422 may urge against the actuating surfaces 442, pushing the tabs 440 inwardly into engagement with the shaft 410. This will help lock the shaft 410 in place with respect to the base 430. Rotating the actuator 422 in the opposite direction will allow the tabs 440 to resiliently return toward a rest position wherein they do not brake movement of the shaft 410. The force with which the shaft 410 engages the dura mater 20 (not shown) then can be adjusted to a desired level by moving the shaft 410 with respect to the base 430. When the shaft 410 is in the desired position, the actuator 422 may be moved into engagement with the tabs 440 to hold the shaft 410 in the desired position.
The contact surface 455 of the shaft 452 is pushed against the surface of the dura mater 20 with a predictable force by means of a spring 454 received in the recess 466. In
In another embodiment (not shown), the spring 454 comprises a compressed elastomer, which may take the form of a column that fills some or all of the diameter of the recess 466. The elastomer may comprise a biocompatible polymeric material, for example. In such an embodiment, the elastomer may be electrically conductive, e.g., by filling a polymeric material with a suitable quantity of a conductive metal powder or the like. In another embodiment, one or more wires may be embedded in the elastomeric material to conduct an electrical signal across the elastomer to the shaft 452.
In the illustrated embodiment and the alternative embodiment wherein the spring 454 comprises an elastomer, the head 460 may be formed of a dielectric material, helping electrically insulate the skull 10 from the shaft 452. In an alternative embodiment, the head 460 may be formed of an electrically conductive material. Even though the other structural elements of the electrode 450 may remain largely the same, this would avoid the necessity of having the lead 468 extend through the head 460; an electrically conducive ring 122 or the like instead may be employed in a manner analogous to that shown in
The contact surface 481 of the shaft 480 is pushed against the surface of the dura mater 20 with a predictable force by means of a spring 486. The spring 486 may be substantially the same as the spring 454 shown in
The electrode 475 of
To implant the electrode 500 in the skull 10, the shaft 510 may be advanced into a bore in the skull until the contact surface 515 exerts the desired contact force against the dura mater 20. Once the shaft 510 is in the desired position, the compressive force F on the collar 540 may be released, allowing the collar 540 to expand outwardly into compressive engagement with the lumen of the bore in the skull 10. This will help hold the electrode 500 in place with respect to the skull without requiring permanent anchoring of the shaft 510 to the skull 10.
The shaft 510 may be electrically coupled to a pulse system (not shown) by a lead 520. The lead 520 may include a cap 522 having an electrically conductive inner surface 524 coupled to a body 526 of the lead. The lead 520 may be analogous to the lead 160 shown in FIGS. 3A-B. Any other suitable electrical connection between the shaft 510 and the pulse system may be employed.
In one embodiment, the collar 540 comprises a dielectric material. This will help electrically insulate the skull 10 from the shaft 510. In another embodiment, the collar 540 is electrically conductive and the lead 520 may be electrically coupled to the shaft 510 via the collar 540.
In the embodiment shown in
In use, the conductive member 570 may be slid freely through a pilot hole 11 formed through the skull to position the tip 574 at the target site 28 in a known manner. The pilot hole 11 may be larger than the conductive member 570 or be tapped to receive the threads of the shaft 560. With the conductive member 570 in place, the shaft 560 may be threaded into the pilot hole 11, crimping the conductive member 570 against an interior of the pilot hole 11. This will fix the conductive member 570 in place. If so desired, a proximal length 572 of the conductive member 570 may extend outwardly of the skull and be held in place by the head 562. The threads of the threaded shaft 560 may also cut through the dielectric sheath of the conductive member 570 as the shaft 560 is screwed into place, making electrical contact with the conductive wire therein.
The gimbal fitting 630 is adapted to allow an operator greater control over the placement of the electrically conductive tip 574 of the conductive member 570. In use, the tip 574 of the conductive member 570 will be threaded through an opening in the gimbal fitting 630. By pivoting the gimbal fitting 630 with respect to the threaded shaft 620 of the head 610, the angular orientation of the conductive member 570 with respect to the pilot hole 11 in the skull 10 can be accurately controlled. Once the operator determines that the conductive member 570 is at the appropriate angle, e.g., using a surgical navigation system such as that noted below, the operator may advance the conductive member 570 to position the conductive tip 574 at the target site 28. Once the tip 574 is in position, the cap 162 of a lead 160 may be press-fitted on the body 610 of the electrode 600. This will crimp the proximal length 572 of the connective member 570 between the body 610 and the conductive inner surface 163 of the cap 162, providing an effective electrical connection between the conductive member 570 and the body 164 of the lead 160.
In an embodiment shown in
In one embodiment, the first electrode 810 comprises at least one electrical contact 815 carried by a distal portion of a shaft 816. A first lead wire 830 may be coupled to the first electrode's contact 815. The second electrode 820 may comprise an elongate member 822 that carries one or more conductive portions, sections, segments, and/or contacts 825, in a manner identical, essentially identical, or analogous to that described above. A second lead wire 835 may be coupled to the second electrode's contact(s) 825. The length of the second electrode 820, the position of one or more contacts 825 carried by the second electrode 820, and/or the particular contacts 825 that are electrically active at any given time may depend upon a targeted tissue type or location and/or establishment of a desired type of stimulation and/or monitoring configuration. In one embodiment, each electrode 810, 820 can provide independently controlled stimulation signals. In another embodiment, one of the electrodes 810, 820 can be coupled to a transmitter to provide stimulation signals to the patient, and the other can be coupled to a sensor to receive diagnostic signals from the patient. The electrodes 810, 820 can be coupled to a common ground, or can be coupled to independent grounds.
In a manner identical, essentially identical, or analogous to other embodiments described herein, a combined electrode assembly 800 may be comprised of one or more electrically nonconductive portions along with one or more electrically conductive portions. In one embodiment, nonconductive portions 814 and 822 of the first and second electrodes 810 and 820, respectively, may be formed from one or more biocompatible materials (e.g., plastic, silicone, and/or other materials), and conductive portions such as the first and second sets of contacts 815 and 825 may be formed from one or more biocompatible conductive materials (e.g., Titanium, Platinum, and/or other materials).
Through appropriate electrical coupling, for example, by way of leads 830 and 835, to an electrical source such as a pulse generator, one or more contacts 815 may be configured as an anode or a cathode, while other contacts 825 may respectively be configured as a cathode or an anode to facilitate bipolar and/or unipolar stimulation as further described below. For example, a combined electrode assembly 800 may be implanted into a patient such that a local contact portion, which may comprise a distal portion of a shaft 816, resides at, upon, or proximate to a stimulation site; while a remote contact portion, which may comprise a distal portion 826 of an elongate member 822, provides a remote or distant circuit completion site.
In general, the applicability of one or more intracranial electrode embodiments to any given neural stimulation and/or monitoring situation may depend upon the location, depth, and/or spatial boundaries of target neural structures and/or target neural populations under consideration, which may depend upon the nature of a patient's neurological condition or disorder. The extent to which an electric field reaches, penetrates, and/or travels into and/or through target neural structures and/or a target neural population may affect neural stimulation efficiency and/or efficacy. Various intracranial electrode embodiments in accordance with the invention, for example, those described above with reference to
C. Systems Employing Intracranial Electrodes
The pulse system 1050 may be implanted in the body of the patient P at a location remote from the array 1010 of electrodes 100. In the embodiment shown in
In one embodiment, the controller 1060 includes a processor, a memory, and a programmable computer medium. The controller 1060, for example, can be a computer, and the programmable computer medium can be software loaded into the memory of the computer and/or hardware that performs the requisite control functions. In an alternative embodiment suggested by dashed lines in
The controller 1060 is operatively coupled to and provides control signals to the pulse generator 1065, which may include a plurality of channels that send appropriate electrical pulses to the pulse transmitter 1070. The pulse generator 1065 may have N channels, with at least one channel associated with each of N electrodes 100 in the array 1010. The pulse generator 1065 sends appropriate electrical pulses to the pulse transmitter 1070, which is coupled to a plurality of electrodes 1080. In one embodiment, each of these electrodes is adapted to be physically connected to the body 124 of a separate lead, allowing each electrode 1080 to electrically communicate with a single electrode 100 in the array 1010 on a dedicated channel of the pulse generator 1065. Suitable components for the power supply 1055, the integrated controller 1060, the pulse generator 1065, and the pulse transmitter 1070 are known to persons skilled in the art of implantable medical devices.
As shown in
One or more electrodes 100 of arrays 1010 such as those described herein may be provided with electrical signals in a variety of spatially and/or temporally different manners. In some circumstances, one electrode 100 or a subset of the electrodes 100 may have one electrical potential and a different electrode 100 or subset of the electrodes 100 (or, in some embodiments, the housing 1052 of the pulse system 1050) may have a different electrical potential. U.S. patent application Ser. No. 09/978,134, entitled “Systems and Methods for Automatically Optimizing Stimulus Parameters and Electrode Configurations for Neuro-Stimulators” and filed 15 Oct. 2001 (the entirety of which is incorporated herein by reference), suggests ways for optimizing the control of the electrical pulses delivered to the electrodes 100 in an array 1010. The methods and apparatus disclosed therein may be used to automatically determine the configuration of therapy electrodes and/or the parameters for the stimulus to treat or otherwise effectuate a change in neural function of a patient.
In general, neural stimulation efficiency and/or efficacy may be influenced by an extent to and/or manner in which neural stimulation reaches and/or travels into and/or through target neural structures and/or a target neural population, which may be affected by stimulation signal polarity, electrode configuration, and/or electrical contact configuration considerations. The particular neural structures and/or neural populations targeted at any time in a neural stimulation situation, and hence such considerations, may depend upon the nature, severity, and/or spatial boundaries of a patient's neurologic dysfunction.
Various embodiments in accordance with the present invention may be configured to provide bipolar and/or unipolar stimulation at one or more times. Neural stimulation in which both an anode and a cathode are positioned, located, or situated within, essentially across, or proximate to a stimulation site may be defined as bipolar stimulation. Neural stimulation in which one of an anode and a cathode is positioned, located, or situated within or proximate to a stimulation site while a respective corresponding cathode or anode is positioned, located, or situated remote from the stimulation site to provide electrical continuity may be defined as unipolar, monopolar, or isopolar stimulation. Unipolar stimulation may alternatively or additionally be characterized by a biasing configuration in which an anode and a cathode are positioned, located, or situated in different neurofunctional areas or functionally distinct anatomical regions. Those skilled in the art will understand that an anode and a cathode may be defined in accordance with a first phase polarity of a biphasic or polyphasic signal.
In a unipolar configuration, a pulse system 1050 may apply an identical polarity signal to each electrode or electrical contact positioned upon or proximate to one or more stimulation sites. Unipolar stimulation may be defined as anodal unipolar stimulation when an anode is positioned upon or proximate to a stimulation site or a target neural population; and as cathodal unipolar stimulation when a cathode is positioned upon or proximate to a stimulation site or a target neural population.
In various situations, neural stimulation having particular stimulation signal and/or spatial and/or temporal characteristics (e.g., bipolar stimulation, cathodal or anodal unipolar stimulation, mixed-polarity stimulation, varying duty cycle stimulation, varying frequency stimulation, varying amplitude stimulation, spatially or topographically varying stimulation, theta burst stimulation, and/or other types of stimulation applied or delivered in a predetermined, pseudo-random, and/or aperiodic manner at one or more times and/or locations), possibly in association or conjunction with one or more adjunctive or synergistic therapies, may facilitate enhanced symptomatic relief and/or at least partial recovery from neurologic dysfunction.
An adjunctive or synergistic therapy may comprise a behavioral therapy such as a physical therapy activity, a movement and/or balance exercise, an activity of daily living (ADL), a vision exercise, a reading task, a speech task, a memory or concentration task, a visualization or imagination exercise, an auditory activity, an olfactory activity, a relaxation activity, and/or another type of behavior, task, or activity; a drug or chemical substance therapy; and/or another therapy that may be relevant to a patient's functional state, development, and/or recovery.
Neurologic dysfunction to which various embodiments of the present invention may be directed may correspond to, for example, motor, sensory, language, visual, cognitive, neuropsychiatric, auditory, and/or other types of deficits or symptoms associated with stroke, traumatic brain injury, cerebral palsy, Multiple Sclerosis, Parkinson's Disease, essential tremor, a memory disorder, dementia, Alzheimer's disease, depression, bipolar disorder, anxiety, obsessive/compulsive disorder, Post Traumatic Stress Disorder, an eating disorder, schizophrenia, Tourette's Syndrome, Attention Deficit Disorder, a drug addiction, autism, epilepsy, a sleep disorder, a hearing disorder, and/or one or more other states, conditions, and/or disorders. Depending upon embodiment details and/or the nature of a patient's neurologic dysfunction, at least partial symptomatic relief, functional recovery, and/or functional development may occur through mechanisms corresponding or analogous to Long Term Potentiation (LTP), Long Term Depression (LTD), neuroplastic change, and/or compensatory processes.
Various portions of the discussion herein focus on use of intracranial electrodes (e.g., electrodes 100, 150, 200, 250, 300, 350, 400, 450, 475, 500, 550, or 600) in neurostimulation systems. In certain alternative applications, intracranial electrodes may additionally or alternatively be used to monitor electrical potentials, for example, in situations involving electroencephalography or electrocorticography. A suitable electroencephalograph may incorporate a system similar to the neurostimulation system 1000 shown in
In some embodiments, the ETM 910 may comprise a conventional adhesive patch electrode commonly used for providing an electrical coupling to a particular location on a patient. The intracranial electrode 920 may comprise a head 922 coupled to a shaft 924. The head 922 and shaft 924 may be integrally formed of an electrically conductive material forming a conductive core 925 that forms an electrical energy conduit. The conductive core 925 may extend throughout a portion or along the entire length of the electrode 920. The conductive core 925 may be carried by or encased in an electrically insulating material or cladding 921. The conductive core 925 may extend from an upper or proximal contact surface 925 a to a lower or distal contact surface 925 b. Contact surfaces 925 a and 925 b provide a signal exchange interface of the conductive core 925. The conductive core 925 and the insulating material 921 may vary in proportionate dimensions with one another accordingly.
The outer layer 916 may be comprised of essentially any appropriate insulating nonconductive material as is known in the art (e.g., foam). The outer layer 916 may be smooth and flexible to facilitate contouring to the patient's skin surface 30. The gel layer 912, which may be placed in contact with scalp 30, may comprise one or more of an electrically conductive coupling gel 912 a (such as a hydrogel or wet gel), an adhesive gel 912 b, and/or an anesthetic gel 912 c. Electrical coupling gel 912 a may be comprised of a saline composition for enhancing electrical conductivity and decreasing losses between the conductive layer 914 and scalp 30. The adhesive gel 912 b aids in keeping the ETM 910 in place. An anesthetic gel 912 c may be incorporated to possibly reduce or retard sensations that may result from the transfer of electrical signals from the ETM 910 through scalp tissues 30 to the electrode 920.
An outer portion of the electrode 950 may be comprised of an insulating cladding 956 disposed around a conductive core 955. The conductive core 955 can include a first electrical contact portion 955 a and a second conductive contact portion 955 b. It is to be appreciated by those of ordinary skill in the art that the cladding 956 may be comprised of any suitable biocompatible electrically insulating material, such as, but not limited to, polymers and/or ceramic materials. The cladding 956 may contain a plurality of pores 957. Pores 957 may encourage bone regeneration within and about the pores for a more friction enhanced and/or lasting placement within the skull 10. In lieu of pores 957, an exterior portion of the cladding 956 in contact with body tissues may also be formed with a roughened surface (not shown) that may encourage bone growth and/or regeneration. Such enhanced friction and intergrowth between the cladding 956 and the cancellous 18 may provide for a more secure and/or conformal placement, which may reduce or minimize positional migration of the implanted electrodes 950. Other embodiments (not shown) may include variations of the cladding 957 having combinations of compatible insulative materials comprising the exterior; such as for example, an upper proximal portion of the cladding 967 being comprised of a ring-like polymer insulator; and/or a distal or generally distal portion of the cladding 967 being comprised of a ceramic insulator.
The intracranial electrode 960 may also comprise a cladding 966 surrounding a conductive core 965. The cladding 966, comprised of any suitable biocompatible material, may in some embodiments include recesses 967 which may encourage surrounding cancellous tissue 18 to grow within and/or around the recesses 967, thus forming an enhanced bonding between the implanted electrode 960 and the skull 10. This modified bonding may discourage migration of the electrode 960.
The RFID unit 1063 may comprise an RFID reader that may include a transmitter and a receive module, a control unit, and a coupling element (e.g., an antenna). The reader may have three functions: energizing, demodulating, and decoding. In addition, a reader can include or be fitted with an interface that converts RF signals returned from an RFID element 971 into a form that can be passed on to and/or processed by other elements (e.g., a controller 1060) associated with the system 900.
The RFID element 971 may comprise an integrated circuit that is activated when placed in a transmitting field of the RFID unit 1063. The transmitting field may vary depending on specifications of the RFID element 971 and/or RFID unit 1063. When an ETM 910 is placed proximate to the intracranial electrode 970, the RFID unit 1063 may emit an RF signal that may used to power up the electrode's RFID element 971. In one embodiment, in the event that an RFID element 971 corresponds to or provides a particular code and/or other information, electrical signal transmission between the pulse generator 1050 and the ETM 910, and hence to the electrode 970, may be allowed. Such an embodiment may facilitate enhanced security neural stimulation.
The above descriptions of embodiments of the invention are not exhaustive and it is to be appreciated that, although not detailed in every instance, certain characteristics of some embodiments may be applicable to other embodiments. Various embodiments may include characteristics that are identical, essentially identical, or analogous to those described in relation to other embodiments. For example, regarding various embodiments of
As noted above, other embodiments of the invention provide methods of implanting an intracranial electrode and/or methods of installing a neurostimulation system including an implantable intracranial electrode. In the following discussion, reference is made to the particular intracranial electrode 100 illustrated in FIGS. 2A-B and to the neurostimulation system 1000 shown in
As noted above, implanting conventional cortical electrodes typically requires a full craniotomy under general anesthesia to remove a relatively large (e.g., thumbnail-sized or larger) window in the skull. Craniotomies are performed under a general anesthetic and subject the patient to increased chances of infection.
In accordance with one embodiment of the present invention, however, the diameter of the electrode shaft 110 is sufficiently small to permit implantation under local anesthetic without requiring a craniotomy. In this embodiment, a relatively small (e.g., 4 mm or smaller) pilot hole may be formed through at least part of the thickness of the patient's skull adjacent a selected stimulation or monitoring site of the brain. When implanting the electrode 100 of FIGS. 2A-B, it may be advantageous to extend the pilot hole through the entire thickness of the skull. Care should be taken to avoid undue trauma to the brain in forming the pilot hole. In one embodiment, an initial estimate of skull thickness can be made from MRI, CT, or other imaging information. A hand-held drill may be used to form a bore shallow enough to avoid extending through the entire skull. A stylus may be inserted into the pilot hole to confirm that it strikes relatively rigid bone. The drill may then be used to deepen the pilot hole in small increments, checking with the stylus after each increment to detect when the hole passes through the thickness of the inner cortex 14 of the skull 10. If so desired, the stylus may be graduated to allow a physician to measure the distance to the springy dura mater and this information can be used to select an electrode 100 of appropriate length or, if an adjustable-length electrode (e.g., electrode 300 of FIGS. 6A-B) is used, to adjust the electrode to an appropriate length.
The location of the pilot hole (and, ultimately the electrode 100 received therein) can be selected in a variety of fashions. U.S. Patent Application Publication No. US 2002/0087201 and U.S. application Ser. No. 09/978,134 (both of which are incorporated hereinabove), for example, suggest approaches for selecting an appropriate stimulation site. When the desired site has been identified, the physician can bore the pilot hole to guide the contact surface 115 of the electrode 100 to that site. In one embodiment, the physician may use anatomical landmarks, e.g., cranial landmarks such as the bregma or the sagittal suture, to guide placement and orientation of the pilot hole. In another embodiment, a surgical navigation system may be employed to inform the physician during the procedure. Briefly, such systems may employ real-time imaging and/or proximity detection to guide a physician in placing the pilot hole and in placing the electrode 100 in the pilot hole. In some systems, fiducials are positioned on the patient's scalp or skull prior to imaging and those fiducials are used as reference points in subsequent implantation. In other systems, real-time MRI or the like may be employed instead of or in conjunction with such fiducials. A number of suitable navigation systems are commercially available, such as the STEALTHSTATION TREON TGS sold by Medtronic Surgical Navigation Technologies of Louisville, Colo., US.
Once the pilot hole is formed, the threaded electrode 100 may be advanced along the pilot hole until the contact surface 115 electrically contacts a desired portion of the patient's brain. If the electrode 100 is intended to be positioned epidurally, this may comprise relatively atraumatically contacting the dura mater 20; if the electrode is to contact a site on the cerebral cortex, the electrode will be advanced to extend through the dura mater. The electrodes 100 may also be implanted to a selected depth within the cerebral cortex or at a deeper location in the brain.
In one embodiment, the length of the electrode 100 is selected (or adjusted for electrode 300, for example) to achieve the desired level of contact and the electrode will be advanced until a known relationship with the skull is achieved, e.g., when the head 102 compresses the contact ring 122 of the lead 120 against the exterior of the skull 10. In another embodiment, the thickness of the skull 10 need not be known to any significant accuracy before the electrode 100 is implanted. Instead, the electrode 100 may be connected, e.g., via the lead 120, to an impedance monitor and the impedance may be monitored as the electrode 100 is being implanted. It is anticipated that the measured impedance will change when the electrode 100 contacts the dura mater 20. Once this contact is detected, the physician may advance the electrode a small, fixed distance to ensure reliable electrical contact over time.
As noted above, the electrode 100 may be coupled to a lead 120. The timing of this coupling may vary with the nature of the coupling. For a lead 120 employing a contact ring 122 or the like positioned below the head 102, the lead may be coupled to the electrode before the electrode is introduced into the skull. In other embodiments, the lead (e.g., lead 160 of FIGS. 3A-B) may be coupled to the electrode after the electrode is properly positioned with respect to the selected site of the brain. The lead, or at least a length thereof, may be implanted subcutaneously, e.g., by guiding it through a tunnel formed between the implant site and the intended site of a subclavicularly implanted pulse system 1050. The patient's scalp may then be closed over the head 102 of the electrode 100 so the electrode is completely enclosed. This can materially improve patient comfort compared to more conventional systems wherein epilepsy monitoring electrodes or the like extend through the scalp to an extracorporeal connection.
Additionally or alternatively, implant depth may be measured, estimated, or indicated through the use of a depth measurement device or apparatus.
Depending on the depth of the pilot hole 11, intracranial electrodes 11-14 may have shafts of varying lengths S1-S4 that correspond to the demarcated indicators d1-d4. For example, the shaft of intracranial electrode I1, may have a length S1 associated with a distance d, indicated on the device 175. Likewise, intracranial electrodes I2, I3 and I4 may be associated with distances d2, d3, and d4, respectively. The depths of the pilot holes 11 may vary from patient to patient depending on such variables as the age of the patient and/or an implant location in the skull 10.
Once an electrode 100 is in place, an electrical stimulus may be delivered from a pulse system 1050 to the patient's brain via a lead 120 and the electrode 100. In certain embodiments of the invention discussed previously, a plurality of electrodes 100 may be implanted in an array (e.g., array 1010, 1010 a, 1010 b, or 1010 c) in the patient's skull and each of the electrodes 100 may be coupled to the pulse system 1050 by an electrically separate lead 120. The precise nature of the stimulus delivered via the electrode(s) 100 can be varied as desired to diagnose or treat a variety of conditions. The type, pattern, and/or frequency of stimulus may be selected in a manner identical, essentially identical, or analogous to or different from that outlined in U.S. Patent Application Publication No. US 2002/0087201, for example, and/or may be optimized in a manner described in U.S. application Ser. No. 09/978,134.
Unless the context clearly requires otherwise, throughout the description and the claims, the words “comprise,” “comprising,” and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense, that is to say, in a sense of “including, but not limited to.” Words using the singular or plural number also include the plural or singular number, respectively. When the claims use the word “or” in reference to a list of two or more items, that word covers all of the following interpretations of the word: any of the items in the list, all of the items in the list, and any combination of the items in the list.
The above-detailed descriptions of embodiments of the invention are not intended to be exhaustive or to limit the invention to the precise form disclosed above. While specific embodiments of, and examples for, the invention are described above for illustrative purposes, various equivalent modifications are possible within the scope of the invention, as those skilled in the relevant art will recognize. For example, whereas steps are presented in a given order, alternative embodiments may perform steps in a different order. Aspects of the invention described in the context of particular embodiments can be combined or eliminated in other embodiments.
In general, the terms used in the following claims should not be construed to limit the invention to the specific embodiments disclosed in the specification, unless the above-detailed description explicitly defines such terms. While certain aspects of the invention are presented below in certain claim forms, the inventors contemplate the various aspects of the invention in any number of claim forms. Accordingly, the inventors reserve the right to add additional claims after filing the application to pursue such additional claim forms for other aspects of the invention.
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US3650276 *||25 Mar 1969||21 Mar 1972||Inst Demedicina Si Farmacie||Method and apparatus, including a flexible electrode, for the electric neurostimulation of the neurogenic bladder|
|US4019518 *||11 Ago 1975||26 Abr 1977||Medtronic, Inc.||Electrical stimulation system|
|US4140133 *||26 Abr 1977||20 Feb 1979||Moskovsky Oblastnoi Nauchno-Issledovatelsky Institut Akusherstva I Ginekolog Ii||Device for pulse current action on central nervous system|
|US4245645 *||20 Jul 1978||20 Ene 1981||Arseneault Pierre Michel||Self-locking cerebral electrical probe|
|US4308868 *||27 May 1980||5 Ene 1982||The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration||Implantable electrical device|
|US4328813 *||20 Oct 1980||11 May 1982||Medtronic, Inc.||Brain lead anchoring system|
|US4431000 *||23 May 1980||14 Feb 1984||Gatron Corporation||Transcutaneous nerve stimulator with pseusorandom pulse generator|
|US4590946 *||14 Jun 1984||27 May 1986||Biomed Concepts, Inc.||Surgically implantable electrode for nerve bundles|
|US4646744 *||29 Jun 1984||3 Mar 1987||Zion Foundation||Method and treatment with transcranially applied electrical signals|
|US4817634 *||18 Jun 1987||4 Abr 1989||Medtronic, Inc.||Epicardial patch electrode|
|US5002053 *||21 Abr 1989||26 Mar 1991||University Of Arkansas||Method of and device for inducing locomotion by electrical stimulation of the spinal cord|
|US5092835 *||6 Jul 1990||3 Mar 1992||Schurig Janet L S||Brain and nerve healing power apparatus and method|
|US5184620 *||26 Dic 1991||9 Feb 1993||Marquette Electronics, Inc.||Method of using a multiple electrode pad assembly|
|US5193540 *||18 Dic 1991||16 Mar 1993||Alfred E. Mann Foundation For Scientific Research||Structure and method of manufacture of an implantable microstimulator|
|US5282468 *||8 Ene 1992||1 Feb 1994||Medtronic, Inc.||Implantable neural electrode|
|US5299569 *||3 May 1991||5 Abr 1994||Cyberonics, Inc.||Treatment of neuropsychiatric disorders by nerve stimulation|
|US5303705 *||1 May 1992||19 Abr 1994||Nenov Valeriy I||Evoked 23NA MR imaging of sodium currents in the brain|
|US5304206 *||18 Nov 1991||19 Abr 1994||Cyberonics, Inc.||Activation techniques for implantable medical device|
|US5314458 *||24 May 1993||24 May 1994||University Of Michigan||Single channel microstimulator|
|US5405375 *||21 Ene 1994||11 Abr 1995||Incontrol, Inc.||Combined mapping, pacing, and defibrillating catheter|
|US5406957 *||14 Sep 1993||18 Abr 1995||Tansey; Michael A.||Electroencephalic neurofeedback apparatus for training and tracking of cognitive states|
|US5411540 *||3 Jun 1993||2 May 1995||Massachusetts Institute Of Technology||Method and apparatus for preferential neuron stimulation|
|US5417719 *||25 Ago 1993||23 May 1995||Medtronic, Inc.||Method of using a spinal cord stimulation lead|
|US5591216 *||19 May 1995||7 Ene 1997||Medtronic, Inc.||Method for treatment of sleep apnea by electrical stimulation|
|US5593432 *||23 Jun 1993||14 Ene 1997||Neuroware Therapy International, Inc.||Method for neurostimulation for pain alleviation|
|US5601611 *||5 Ago 1994||11 Feb 1997||Ventritex, Inc.||Optical blood flow measurement apparatus and method and implantable defibrillator incorporating same|
|US5611350 *||8 Feb 1996||18 Mar 1997||John; Michael S.||Method and apparatus for facilitating recovery of patients in deep coma|
|US5618531 *||13 Jul 1993||8 Abr 1997||New York University||Method for increasing the viability of cells which are administered to the brain or spinal cord|
|US5707334 *||21 Ago 1995||13 Ene 1998||Young; Robert B.||Method of treating amygdala related transitory disorders|
|US5711316 *||30 Abr 1996||27 Ene 1998||Medtronic, Inc.||Method of treating movement disorders by brain infusion|
|US5713922 *||25 Abr 1996||3 Feb 1998||Medtronic, Inc.||Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain|
|US5713923 *||13 May 1996||3 Feb 1998||Medtronic, Inc.||Techniques for treating epilepsy by brain stimulation and drug infusion|
|US5716377 *||25 Abr 1996||10 Feb 1998||Medtronic, Inc.||Method of treating movement disorders by brain stimulation|
|US5722401 *||13 Nov 1995||3 Mar 1998||Cardiac Pathways Corporation||Endocardial mapping and/or ablation catheter probe|
|US5735814 *||30 Abr 1996||7 Abr 1998||Medtronic, Inc.||Techniques of treating neurodegenerative disorders by brain infusion|
|US5865842 *||29 Ago 1996||2 Feb 1999||Medtronic, Inc.||System and method for anchoring brain stimulation lead or catheter|
|US5871517 *||15 Ene 1997||16 Feb 1999||Somatics, Inc.||Convulsive therapy apparatus to stimulate and monitor the extent of therapeutic value of the treatment|
|US5885976 *||25 Nov 1997||23 Mar 1999||Sandyk; Reuven||Methods useful for the treatment of neurological and mental disorders related to deficient serotonin neurotransmission and impaired pineal melatonin functions|
|US5886769 *||18 May 1998||23 Mar 1999||Zolten; A. J.||Method of training and rehabilitating brain function using hemi-lenses|
|US5893883 *||30 Abr 1997||13 Abr 1999||Medtronic, Inc.||Portable stimulation screening device for screening therapeutic effect of electrical stimulation on a patient user during normal activities of the patient user|
|US6011996 *||20 Ene 1998||4 Ene 2000||Medtronic, Inc||Dual electrode lead and method for brain target localization in functional stereotactic brain surgery|
|US6016449 *||27 Oct 1997||18 Ene 2000||Neuropace, Inc.||System for treatment of neurological disorders|
|US6018682 *||30 Abr 1998||25 Ene 2000||Medtronic, Inc.||Implantable seizure warning system|
|US6021352 *||26 Jun 1996||1 Feb 2000||Medtronic, Inc,||Diagnostic testing methods and apparatus for implantable therapy devices|
|US6024702 *||3 Sep 1997||15 Feb 2000||Pmt Corporation||Implantable electrode manufactured with flexible printed circuit|
|US6026326 *||13 Ene 1997||15 Feb 2000||Medtronic, Inc.||Apparatus and method for treating chronic constipation|
|US6035236 *||13 Jul 1998||7 Mar 2000||Bionergy Therapeutics, Inc.||Methods and apparatus for electrical microcurrent stimulation therapy|
|US6038480 *||17 Feb 1998||14 Mar 2000||Medtronic, Inc.||Living tissue stimulation and recording techniques with local control of active sites|
|US6040180 *||7 May 1997||21 Mar 2000||Neuralstem Biopharmaceuticals, Ltd.||In vitro generation of differentiated neurons from cultures of mammalian multipotential CNS stem cells|
|US6042579 *||30 Abr 1997||28 Mar 2000||Medtronic, Inc.||Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain|
|US6052624 *||7 Ene 1999||18 Abr 2000||Advanced Bionics Corporation||Directional programming for implantable electrode arrays|
|US6055456 *||29 Abr 1999||25 Abr 2000||Medtronic, Inc.||Single and multi-polar implantable lead for sacral nerve electrical stimulation|
|US6176242 *||30 Abr 1999||23 Ene 2001||Medtronic Inc||Method of treating manic depression by brain infusion|
|US6190893 *||18 Sep 1998||20 Feb 2001||Massachusetts Institute Of Technology||Electroactive materials for stimulation of biological activity of bone marrow stromal cells|
|US6198958 *||11 Jun 1998||6 Mar 2001||Beth Israel Deaconess Medical Center, Inc.||Method and apparatus for monitoring a magnetic resonance image during transcranial magnetic stimulation|
|US6205360 *||6 Sep 1996||20 Mar 2001||Cochlear Limited||Apparatus and method for automatically determining stimulation parameters|
|US6205361 *||28 Ene 1999||20 Mar 2001||Advanced Bionics Corporation||Implantable expandable multicontact electrodes|
|US6210417 *||29 Abr 1999||3 Abr 2001||Medtronic, Inc.||Medical lead positioning and anchoring system|
|US6221908 *||31 Dic 1998||24 Abr 2001||Scientific Learning Corporation||System for stimulating brain plasticity|
|US6339725 *||10 Jul 2000||15 Ene 2002||The Board Of Trustees Of Southern Illinois University||Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation|
|US6353754 *||24 Abr 2000||5 Mar 2002||Neuropace, Inc.||System for the creation of patient specific templates for epileptiform activity detection|
|US6354299 *||30 Jun 2000||12 Mar 2002||Neuropace, Inc.||Implantable device for patient communication|
|US6356786 *||20 Ene 2000||12 Mar 2002||Electrocore Techniques, Llc||Method of treating palmar hyperhydrosis by electrical stimulation of the sympathetic nervous chain|
|US6356792 *||20 Ene 2000||12 Mar 2002||Electro Core Technologies, Llc||Skull mounted electrode lead securing assembly|
|US6360122 *||2 Ago 2000||19 Mar 2002||Neuropace, Inc.||Data recording methods for an implantable device|
|US6366813 *||25 Jun 1999||2 Abr 2002||Dilorenzo Daniel J.||Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease|
|US6375666 *||9 Dic 1999||23 Abr 2002||Hans Alois Mische||Methods and devices for treatment of neurological disorders|
|US6505075 *||22 May 2000||7 Ene 2003||Richard L. Weiner||Peripheral nerve stimulation method|
|US6507755 *||3 Mar 1999||14 Ene 2003||Neurometrix, Inc.||Apparatus and method for stimulating human tissue|
|US6529774 *||9 Nov 2000||4 Mar 2003||Neuropace, Inc.||Extradural leads, neurostimulator assemblies, and processes of using them for somatosensory and brain stimulation|
|US6539263 *||7 Jun 2000||25 Mar 2003||Cornell Research Foundation, Inc.||Feedback mechanism for deep brain stimulation|
|US6556868 *||14 Ene 2002||29 Abr 2003||The Board Of Trustees Of Southern Illinois University||Methods for improving learning or memory by vagus nerve stimulation|
|US6684105 *||31 Ago 2001||27 Ene 2004||Biocontrol Medical, Ltd.||Treatment of disorders by unidirectional nerve stimulation|
|US6687525 *||7 Jun 2001||3 Feb 2004||New York University||Method and system for diagnosing and treating thalamocortical dysrhythmia|
|US6690974 *||11 Sep 2001||10 Feb 2004||Neuropace, Inc.||Stimulation signal generator for an implantable device|
|US6708064 *||24 Dic 2001||16 Mar 2004||Ali R. Rezai||Modulation of the brain to affect psychiatric disorders|
|US6725094 *||17 Sep 2001||20 Abr 2004||Lloyd R. Saberski||Apparatus and methods for reducing pain and/or retraining muscles|
|US6839594 *||26 Abr 2001||4 Ene 2005||Biocontrol Medical Ltd||Actuation and control of limbs through motor nerve stimulation|
|US6850802 *||20 Mar 2003||1 Feb 2005||Medtronic, Inc.||Selective brain stimulation using conditioning pulses|
|US6873872 *||11 Oct 2002||29 Mar 2005||George Mason University||Adaptive electric field modulation of neural systems|
|US6990377 *||26 Abr 2004||24 Ene 2006||Northstar Neuroscience, Inc.||Systems and methods for facilitating and/or effectuating development, rehabilitation, restoration, and/or recovery of visual function through neural stimulation|
|US7006859 *||18 Jul 2003||28 Feb 2006||Flint Hills Scientific, L.L.C.||Unitized electrode with three-dimensional multi-site, multi-modal capabilities for detection and control of brain state changes|
|US7010351 *||8 Mar 2001||7 Mar 2006||Northstar Neuroscience, Inc.||Methods and apparatus for effectuating a lasting change in a neural-function of a patient|
|US7024247 *||24 Ene 2003||4 Abr 2006||Northstar Neuroscience, Inc.||Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures|
|US7187968 *||23 Oct 2003||6 Mar 2007||Duke University||Apparatus for acquiring and transmitting neural signals and related methods|
|US20050004620 *||30 Abr 2004||6 Ene 2005||Medtronic, Inc.||Implantable medical device with anti-infection agent|
|US20050015129 *||11 May 2004||20 Ene 2005||Mische Hans A.||Methods and devices for the treatment of neurological and physiological disorders|
|US20050021104 *||5 Abr 2004||27 Ene 2005||Dilorenzo Daniel John||Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease|
|US20050021105 *||6 Ago 2004||27 Ene 2005||Firlik Andrew D.||Methods and apparatus for effectuating a change in a neural-function of a patient|
|US20050021106 *||6 Ago 2004||27 Ene 2005||Firlik Andrew D.||Methods and apparatus for effectuating a lasting change in a neural-function of a patient|
|US20050021107 *||6 Ago 2004||27 Ene 2005||Firlik Andrew D.||Methods and apparatus for effectuating a lasting change in a neural-function of a patient|
|US20050021118 *||25 Jun 2004||27 Ene 2005||Chris Genau||Apparatuses and systems for applying electrical stimulation to a patient|
|US20050033378 *||9 Dic 2003||10 Feb 2005||Sheffield Warren Douglas||Methods for treating and/or collecting information regarding neurological disorders, including language disorders|
|US20050070971 *||2 Ago 2004||31 Mar 2005||Brad Fowler||Apparatus and methods for applying neural stimulation to a patient|
|US20050075679 *||7 May 2004||7 Abr 2005||Gliner Bradford E.||Methods and apparatuses for treating neurological disorders by electrically stimulating cells implanted in the nervous system|
|US20050075680 *||15 Jul 2004||7 Abr 2005||Lowry David Warren||Methods and systems for intracranial neurostimulation and/or sensing|
|US20060004423 *||9 Sep 2005||5 Ene 2006||Boveja Birinder R||Methods and systems to provide therapy or alleviate symptoms of chronic headache, transformed migraine, and occipital neuralgia by providing rectangular and/or complex electrical pulses to occipital nerves|
|US20060015153 *||15 Jul 2005||19 Ene 2006||Gliner Bradford E||Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy|
|US20070088404 *||19 Oct 2005||19 Abr 2007||Allen Wyler||Methods and systems for improving neural functioning, including cognitive functioning and neglect disorders|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US7672730||24 Jun 2003||2 Mar 2010||Advanced Neuromodulation Systems, Inc.||Methods and apparatus for effectuating a lasting change in a neural-function of a patient|
|US7684866||2 Ago 2004||23 Mar 2010||Advanced Neuromodulation Systems, Inc.||Apparatus and methods for applying neural stimulation to a patient|
|US7729773||18 Oct 2006||1 Jun 2010||Advanced Neuromodualation Systems, Inc.||Neural stimulation and optical monitoring systems and methods|
|US7742820||18 Jul 2006||22 Jun 2010||Advanced Neuromodulation Systems, Inc.||Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects|
|US7756584||27 Sep 2002||13 Jul 2010||Advanced Neuromodulation Systems, Inc.||Methods and apparatus for effectuating a lasting change in a neural-function of a patient|
|US7801601||27 Ene 2006||21 Sep 2010||Cyberonics, Inc.||Controlling neuromodulation using stimulus modalities|
|US7831305||15 Oct 2002||9 Nov 2010||Advanced Neuromodulation Systems, Inc.||Neural stimulation system and method responsive to collateral neural activity|
|US7869867||27 Oct 2006||11 Ene 2011||Cyberonics, Inc.||Implantable neurostimulator with refractory stimulation|
|US7869885||28 Abr 2006||11 Ene 2011||Cyberonics, Inc||Threshold optimization for tissue stimulation therapy|
|US7908009||18 Jul 2006||15 Mar 2011||Advanced Neuromodulation Systems, Inc.||Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects|
|US7917225||18 Jul 2006||29 Mar 2011||Advanced Neuromodulation Systems, Inc.||Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects|
|US8043304 *||24 Jul 2008||25 Oct 2011||Boston Scientific Neuromodulation Corporation||Cam lock burr hole plug for securing retainer/plug base|
|US8068892 *||13 Jun 2008||29 Nov 2011||Aaken Labs||Methods and systems for using intracranial electrodes|
|US8145319 *||11 Oct 2005||27 Mar 2012||Ebi, Llc||Methods and devices for treatment of osteonecrosis of the femoral head with core decompression|
|US8182540 *||28 Mar 2008||22 May 2012||National Cheng Kung University||Skull endosseous implant|
|US8315686||30 Ene 2009||20 Nov 2012||New York University||Cortical electrode array and method for stimulating and recording brain activity|
|US8417353||29 Abr 2009||9 Abr 2013||Medtronic, Inc.||Method and apparatus for securing an electrode|
|US8425534||24 Jul 2008||23 Abr 2013||Boston Scientific Neuromodulation Corporation||Cam lock burr hole plug for securing stimulation lead|
|US8464716||12 May 2010||18 Jun 2013||Alterg, Inc.||Differential air pressure systems|
|US8761889||19 Sep 2008||24 Jun 2014||Neuropace, Inc.||Systems, methods and devices for a skull/brain interface|
|US8764767||19 Mar 2013||1 Jul 2014||Boston Scientific Neuromodulation Corporation||Cam lock burr hole plug for securing stimulation lead|
|US8805539||14 Mar 2013||12 Ago 2014||Medtronic, Inc.||Method and apparatus for securing an electrode|
|US8840572||23 Sep 2008||23 Sep 2014||Alterg, Inc.||System, method and apparatus for applying air pressure on a portion of the body of an individual|
|US8938290||30 Oct 2008||20 Ene 2015||Neuropace, Inc.||Systems, methods and devices for a skull/brain interface|
|US8965513||29 Oct 2008||24 Feb 2015||Neuropace, Inc.||Systems, methods and devices for a skull/brain interface|
|US9031658||14 Oct 2008||12 May 2015||Board Of Regents, The University Of Texas System||Wireless neural recording and stimulating system|
|US9084901 *||28 Abr 2006||21 Jul 2015||Medtronic, Inc.||Cranial implant|
|US9108041||25 Nov 2013||18 Ago 2015||Dignity Health||Microburst electrical stimulation of cranial nerves for the treatment of medical conditions|
|US20040088024 *||24 Jun 2003||6 May 2004||Firlik Andrew D.||Methods and apparatus for effectuating a lasting change in a neural-function of a patient|
|US20040102828 *||18 Abr 2003||27 May 2004||Lowry David Warren||Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography|
|US20040111127 *||10 Dic 2002||10 Jun 2004||Gliner Bradford Evan||Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders|
|US20040158298 *||15 Oct 2001||12 Ago 2004||Gliner Bradford Evan||Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators|
|US20040181263 *||9 Dic 2003||16 Sep 2004||Jeffrey Balzer||System and method for treating Parkinson's Disease and other movement disorders|
|US20050021105 *||6 Ago 2004||27 Ene 2005||Firlik Andrew D.||Methods and apparatus for effectuating a change in a neural-function of a patient|
|US20050021107 *||6 Ago 2004||27 Ene 2005||Firlik Andrew D.||Methods and apparatus for effectuating a lasting change in a neural-function of a patient|
|US20050075680 *||15 Jul 2004||7 Abr 2005||Lowry David Warren||Methods and systems for intracranial neurostimulation and/or sensing|
|US20050274589 *||6 May 2005||15 Dic 2005||Vanderlande Industries Nederland B.V.||Device for sorting products|
|US20070255338 *||28 Abr 2006||1 Nov 2007||Medtronic, Inc.||Cranial implant|
|US20120046531 *||21 Dic 2010||23 Feb 2012||Sherwin Hua||Insertion of medical devices through non-orthogonal and orthogonal trajectories within the cranium and methods of using|
|WO2007089394A2 *||9 Ene 2007||9 Ago 2007||Cyberonics Inc||Controlling neuromodulation using stimulus modalities|
|WO2009051965A1 *||1 Oct 2008||23 Abr 2009||Univ Texas||A wireless neural recording and stimulating system for pain management|
|WO2010035203A1 *||21 Sep 2009||1 Abr 2010||Dr. Langer Medical Gmbh||Electrode for intraoperative nerve stimulation|
|WO2014001501A2 *||28 Jun 2013||3 Ene 2014||Plugmed Heart||Endosseous assembly for percutaneous connector|
|Clasificación de EE.UU.||607/45|
|Clasificación cooperativa||A61N1/36025, A61N1/0531, A61N1/0539, A61N1/36017, A61N1/375, A61N1/0534|
|Clasificación europea||A61N1/05K1S, A61N1/05K1D, A61N1/05K1C, A61N1/36E2, A61N1/36, A61N1/36E|
|16 Dic 2004||AS||Assignment|
Owner name: NORTHSTAR NEUROSCIENCE, INC., WASHINGTON
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOWRY, DAVID W.;FOWLER, BRAD;THOMPSON, GENE;REEL/FRAME:016086/0167;SIGNING DATES FROM 20041118 TO 20041124
|12 Jun 2009||AS||Assignment|
Owner name: ADVANCED NEUROMODULATION SYSTEMS, INC.,TEXAS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NORTHSTAR NEUROSCIENCE, INC.;REEL/FRAME:022813/0542
Effective date: 20090521